LifeVantage to Announce Second Quarter Fiscal Year 2026 Results on February 4, 2026
Rhea-AI Summary
LifeVantage (Nasdaq:LFVN) will release second quarter fiscal 2026 results for the quarter ended December 31, 2025 after market close on Wednesday, February 4, 2026. The company will host an investor conference call the same day at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) with U.S. dial-in (877) 704-4453 and international dial-in (201) 389-0920.
A telephone replay will be available about two hours after the call and accessible through Wednesday, February 18, 2026 via U.S. replay (844) 512-2921 or international (412) 317-6671 using confirmation code 13757766. A simultaneous live webcast will stream on the Investor Relations site and will be archived for approximately 30 days.
Positive
- None.
Negative
- None.
News Market Reaction – LFVN
In the Jan 22 session, LFVN gained 4.74%, reflecting a moderate positive market reaction. Argus tracked a trough of -2.7% from its starting point during tracking. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 12 | Product/event update | Positive | +4.6% | Global Kickoff event and product integration announcements. |
| Jan 07 | Leadership change | Positive | +1.6% | Appointment of CTO to drive digital transformation. |
| Jan 06 | Conference participation | Positive | +0.5% | ICR Conference participation with leadership presentation. |
| Dec 10 | Investor event | Positive | +1.2% | Water Tower fireside chat with CEO and CFO. |
| Nov 12 | Clinical/preclinical data | Positive | +0.9% | In vitro results showing P84 effects on gut peptides. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent company news, mainly product, leadership, and event updates, was followed by modestly positive price reactions, contrasting with today’s decline on a neutral earnings-date announcement.
Over the last few months, LifeVantage issued several operational and product-focused updates. A virtual Global Kickoff on Jan 12, 2026 highlighting the LoveBiome integration and digital tools coincided with a 4.62% gain. Executive appointments, conference participation, and positive in vitro data on the P84 formula all saw smaller positive moves. Against this backdrop, today’s earnings date announcement arrives as the stock trades near its 52-week low and below its 200-day average.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SALT LAKE CITY, Jan. 21, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its second quarter ended December 31, 2025, after the stock market closes on Wednesday, February 4, 2026. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.
Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approximately two hours after the call concludes and will be available through Wednesday, February 18, 2026, by dialing (844) 512-2921 from the U.S. and entering confirmation code 13757766, or (412) 317-6671 from international locations, and entering confirmation code 13757766.
There will also be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at https://lifevantage.gcs-web.com/events-and-presentations or directly at https://viavid.webcasts.com/starthere.jsp?ei=1747727&tp_key=af8ec2b531. The webcast will be archived for approximately 30 days.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, MindBody GLP-1 System™, and the comprehensive gut activator, P84, and activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com
